Identifying Mechanism of Resveratrol for the Treatment of COVID-19 and Idiopathic Pulmonary Fibrosis via Suppressing Inflammation Response Through IL-17 Signaling Pathway from the Perspectives of in silico Study
Our research elucidates the targets, pathways and pathophysiological processes of RSV involved in the effects of anti-COVID-19 and IPF, suggesting RSV could be a therapeutic candidate for reducing infection and fibrosis.
Authors
- Jiamiao Shi
- Qinru Sun (ORCID: https://orcid.org/0000-0001-6203-8539)
- Ning Jia (ORCID: https://orcid.org/0000-0001-6434-170X)
- Jiahao Wang (ORCID: https://orcid.org/0000-0003-2957-764X)
Institutions
- Xi'an Jiaotong University (CN)
Publication Details
- Journal
- Current Medicinal Chemistry
- Published
- 2024-10-14
- DOI
- https://doi.org/10.2174/0109298673308841240930044555
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00